Clinical Trial Update: Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating reduced-target resection after induction chemotherapy in resectable recurrent nasopharyngeal carcinoma is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma, De-escaltion Therapy | Phase 3 | Status: RECRUITING